Pharmaceuticals
Suvoda's latest platform release creates a global experience across study data, patient engagement, scheduling, payments, and clinical trial operations
CONSHOHOCKEN, Pa., Sept. 30, 2026 /PRNewswire/ -- Suvoda
2026-09-30 22:00
2791
The 94th CMEF, the World's Leading Medical Device Industry Event, Set to Open in Beijing Oct. 21-24
BEIJING, Sept. 30, 2026 /PRNewswire/ -- The 94th China International Medical Equipment Fair (CMEF) and concurrent events—including ICMD, covering medical device design and manufacturing; CRS, focusing on rehabilitation and assistive technology; CECN, dedicated to elderly care and nursing; and Hea...
2026-09-30 21:16
1723
Zhendong Pharmaceutical Announces Publication of Phase IIb Study of Investigational Vaginal Lactobacillus Capsule in the National Medical Journal of China
BEIJING, Sept. 30, 2026 /PRNewswire/ -- Zhendong Pharmaceutical
2026-09-30 20:00
1466
Tamarind Health launches Rare Cancer Centre to make specialist expertise easier to access
New Rare Cancer Centre brings together expertise in rare and complex cancers, giving patients, families and referring physicians a single point of access to specialist care. SINGAPORE, Sept. 30, 2026 /PRNewswire/ -- Marking Rare Cancer Day, Tamarind Health today announced the launch of its Rare ...
2026-09-30 13:28
1646
Telix Granted FDA Fast Track Designation for BiPASS Pre-Biopsy Prostate Cancer Imaging
* FDA Fast Track designation granted for Telix's BiPASS® program, which is evaluating68Ga-PSMA-PET imaging alongside MRI in the pre-biopsy prostate cancer setting. * The designation recognizes the program's potential to address an important unmet need by enabling an imaging-first approach to ...
2026-09-30 08:26
1806
Vitaceuticals Founders Win National Manufacturing Award for Australian-Made Health Range
Pharmacists Sally Tadros and Cyndi Khawaja recognised at the 2026 Australian Women's Small Business Champion Awards. SYDNEY, Sept. 29, 2026 /PRNewswire/ -- Sydney pharmacists and sisters Sally Tadros and Cyndi Khawaja have won the Manufacturing category at the 2026 Australian Women's Small Busin...
2026-09-29 09:16
1155
Ascletis Announces Positive Results from 28-Day Proof-of-Concept Clinical Study in U.S. for ASC50, a First-in-Class and Best-in-Class Oral Small Molecule IL-17A Inhibitor for the Treatment of Plaque Psoriasis
- 48.9% placebo-adjusted reduction in psoriasis area and severity index (PASI) score achieved in mild-to-moderate plaque psoriasis patients with once-daily 200 mg 28-day treatment. - Steady-state elimination half-life after 28-day treatment in patients was 6.5 days, supporting potential once-wee...
2026-09-29 08:00
2542
Link Cell Therapies Initiates Clinical Dosing with Logic-Gated CAR-T Therapy, Expands Executive Leadership, and Upsizes Series A Financing to $90 Million
– LNK001, an AND-gated CAR-T therapy targeting CAIX and ENPP3, is being evaluated in a Phase 1 study in advanced clear cell renal cell carcinoma at MD Anderson Cancer Center – – Jie D'Elia, Ph.D., joins as Chief Executive Officer and Friedrich Graf Finckenstein, M.D., as Chief Medical Officer; c...
2026-09-28 18:59
2729
Lundbeck to establish global innovation hub in Greater Boston and relocate US headquarters
* The new hub in Greater Boston will bring Lundbeck closer to one of the world's leading life sciences ecosystems, strengthening access to science, talent and partnerships. * The move is part of Lundbeck's continued investment in the US, a key market, and will support the company's Focused In...
2026-09-25 15:52
3388
Basecamp Research raises $140M to advance AI-designed therapeutics
/C O R R E C T I O N -- Basecamp Research/ In the news release, Basecamp Research raises $140M to advance AI-designed therapeutics, issued 23-Sep-2026 by Basecamp Research over PR Newswire, we are advised by the company that information has changed in the first bulleted subheadline and in the fo...
2026-09-25 01:44
2825
Daewoong Pharmaceutical Presents Baseline Characteristics of 104 Patients in Global Phase 2 Trial for IPF Drug Candidate 'Bersiporocin' at ERS 2026
* 104 IPF patients enrolled in US and South Korea as global Phase 2 trial progresses toward completion * Study includes both antifibrotic-treated and untreated patients; top-line data expected in H1 2027 * First-in-class PRS inhibitor being developed as a potential new therapeutic option...
2026-09-24 08:00
2985
Basecamp Research raises $140M to advance AI-designed therapeutics
* Oversubscribed Series C led by S32 with backing from NVIDIA and others * Funding will advance a pipeline of EDEN-designed therapeutics, starting with in vivo cell therapy, and expand pharmaceutical partnerships * The company has demonstrated strong preclinical results across multiple modal...
2026-09-23 21:00
1315
Werfen Announces US FDA 510(k) Clearance and CE Mark for Aptiva® Antiphospholipid Syndrome IgA Reagent
FDA Clearance and CE Mark Complete Aptiva's Antiphospholipid Syndrome Portfolio, Expanding Global Access to Comprehensive APS Testing SAN DIEGO, Sept. 23, 2026 /PRNewswire/ -- Werfen today announced that its Aptiva Antiphospholipid Syndrome (APS) Immunoglobulin A (IgA) Reagent has received both ...
2026-09-23 20:00
1682
HKSH Medical Group and United Imaging Mark Launch of Hong Kong's First Long-Axial PET/CT
HONG KONG, Sept. 23, 2026 /PRNewswire/ -- HKSH Medical Group (HKSH) and United Imaging Healthcare (United Imaging) announced on September 23 the arrival of Hong Kong's first long-axial PET/CT, the uMI Panorama GS, at HKSH Cancer Centre, providing a new technology platform for molecular imaging cl...
2026-09-23 18:30
1433
Novo receives Singapore approval for Wegovy® as first treatment for MASH with liver fibrosis
ESSENCE trial data showed 63% of participants receiving semaglutide achieved steatohepatitis resolution without worsening of liver fibrosis, compared with 34% receiving placebo, at Week 72. * Singapore's Health Sciences Authority (HSA) has approved Wegovy® (once-weekly injectable semaglutide 2...
2026-09-23 10:05
3244
Kazia Therapeutics Announces Sovargen Co. Doses First Patient in Phase 1b/2a Trial of Paxalisib for Rare Seizure Disorders
Clinical Milestone Expands Development of Paxalisib Beyond Oncology and
Triggers $2 Million Payment to Kazia
SYDNEY, Sept. 22, 2026 /PRNewswire/ -- Kazia Therapeutics Limited
2026-09-22 19:30
2382
Multiple Sacituzumab Tirumotecan (sac-TMT) Studies Selected as LBAs at ESMO 2026, OptiTROP-Lung04 and OptiTROP-Lung06 to be Presented in the Lung Cancer Session
CHENGDU, China, Sept. 22, 2026 /PRNewswire/ -- The 2026 European Society for Medical Oncology (ESMO) Congress will be held in Madrid, Spain, from October 23 to 27. Multiple Phase III clinical studies of the TROP2 ADC sacituzumab tirumotecan (sac-TMT, also known as SKB264/MK-2870) (佳泰莱®) developed...
2026-09-22 15:48
2030
6 countries across Terumo Asia Pacific officially recognized as Best Workplaces™ Certified by Great Place To Work®
SINGAPORE, Sept. 21, 2026 /PRNewswire/ -- Terumo is proud to announce that 6
countries across Terumo Asia Pacific have officially been recognized as Best
Workplaces™ Certified by Great Place To Work®.
2026-09-21 12:00
877
MALAYSIA HEALTHCARE DEEPENS BANGLADESH PRESENCE AS MEDICAL TOURISM DEMAND GROWS
CHATTOGRAM, Bangladesh, Sept. 21, 2026 /PRNewswire/ -- Malaysia Healthcare Travel Council (MHTC) deepened its engagement in Bangladesh through Malaysia Healthcare Week in Bangladesh, held from 16 to 21 September, bringing Malaysian hospitals and healthcare stakeholders together across Dhaka and C...
2026-09-21 10:41
2264
Telix and ITM Join Forces to Create a Radiopharmaceutical Powerhouse
* Transformational merger reinforces Telix's long-term growth strategy as a vertically integrated radiopharmaceutical company with enhanced capabilities across development, isotope production and global manufacturing, underpinned by commercial excellence and the industry's most extensive therap...
2026-09-21 09:59
2269
Week's Top Stories
Most Reposted
SALMON SECURES $140 MILLION (PHP 8.8 BILLION) TO DOUBLE DOWN ON THE GROWTH OPPORTUNITY IN THE PHILIPPINES
[Picked up by 282 media titles]
2026-10-19 13:18
Infobip and Yamaha Power Conversational Customer Engagement in Indonesia's Automotive Sector
[Picked up by 275 media titles]
2026-10-21 15:00
DayOne Supports NVIDIA DSX POD Reference Design, Advancing Standardized Infrastructure for AI
[Picked up by 270 media titles]
2026-10-22 11:55Carro Establishes Inaugural SGD450 Million Asset-Backed Securitisation Warehouse Facility
[Picked up by 267 media titles]
2026-10-22 11:00Ready Server Launches ReadyServer LLM API, Giving Every VPS Customer Private AI Inference at No Extra Cost
[Picked up by 265 media titles]
2026-10-20 14:10Most Read
Home 3D Printers are More Accessible Than Ever This Black Friday with Bambu Lab
2026-10-22 17:00
14737
SALMON SECURES $140 MILLION (PHP 8.8 BILLION) TO DOUBLE DOWN ON THE GROWTH OPPORTUNITY IN THE PHILIPPINES
2026-10-19 13:18
12082
FinDev Canada provides a USD 60 million loan to Muangthai Capital to advance gender equality and private sector investment in Thailand
2026-10-17 00:54
12000
BUUU Group Limited Announces 10-for-1 Forward Share Split
2026-10-17 04:30
11371